Karyopharm Therapeutics
KPTI
#8602
Rank
HK$0.80 B
Marketcap
HK$6.47
Share price
14.66%
Change (1 day)
-32.27%
Change (1 year)

EPS for Karyopharm Therapeutics (KPTI)

EPS in 2023 (TTM): -HK$10.34

According to Karyopharm Therapeutics 's latest financial reports the company's current EPS (TTM) is -HK$10.29. In 2022 the company made an earnings per share (EPS) of -HK$15.82 a decrease over its 2021 EPS that were of -HK$12.94.

EPS history for Karyopharm Therapeutics from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$10.34-34.68%
2022-HK$15.8222.29%
2021-HK$12.94-39.19%
2020-HK$21.28-15.48%
2019-HK$25.183.19%
2018-HK$24.4011.79%
2017-HK$21.83-4.44%
2016-HK$22.84-11.75%
2015-HK$25.8837.76%
2014-HK$18.79-74.5%
2013-HK$73.67

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
HK$14.20-238.01%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$30.95-400.76%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$23.17-325.17%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$2.21-121.46%๐Ÿ‡บ๐Ÿ‡ธ USA